A new role for T cells in dampening innate inflammatory responses

Science China Life Sciences

Volumn 53, Issue 2, 2010, Pages 190-194

  Tang, Hong ^a   Fu, Yang Xin ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INNATE IMMUNITY; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES;

EID: 77949308843     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-0040-5     Document Type: Review

References (59)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature, 2008, 454: 428-435.
2. Medzhitov R. Approaching the asymptote: 20 years later. Immunity, 2009, 30: 766-775.
3. Zhao J, Yang X, Auh S L, et al. Do adaptive immune cells suppress or activate innate immunity? Trends Immunol, 2009, 30: 8-12.
4. Cavaillon J M, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res, 2006, 12: 151-170.
5. Brooks D G, Trifilo M J, Edelmann K H, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med, 2006, 12: 1301-1309.
6. Sharpe A H, Wherry E J, Ahmed R, et al. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol, 2007, 8: 239-245.
7. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol, 2001, 2: 675-680.
8. Janeway C A J, Medzhitov R. Innate immune recognition. Annu Rev Immunol, 2002, 20: 197-216.
9. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev, 2009, 227: 75-86.
10. Takaoka A, Wang Z, Choi M K, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 2007, 448: 501-505.
11. Schroder K, Muruve D A, Tschopp J. Innate immunity: Cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol, 2009, 19: R262-265.
12. Sabbah A, Chang T H, Harnack R, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol, 2009, 10: 1073-1080.
13. O'Neill L A. DNA makes RNA makes innate immunity. Cell, 2009, 138: 428-430.
14. Medzhitov R, Janeway C A J. Innate immunity: The virtues of a nonclonal system of recognition. Cell, 1997, 91: 295-298.
15. Stout R D, Bottomly K. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol, 1989, 142: 760-765.
16. Monney L, Sabatos C A, Gaglia J L, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature, 2002, 415: 536-541.
17. Duffield J S. The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond) 2003, 104: 27-38.
18. Foster P S, Hogan S P, Ramsay A J, et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med, 1996, 183: 195-201.
19. + T cells. J Exp Med, 1993, 177: 573-576.
20. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis, 1993, 147: 901-907.
21. Beaven M A, Metzger H. Signal transduction by Fc receptors: The Fc epsilon RI case. Immunol Today, 1993, 14: 222-226.
22. Cooper N R. The classical complement pathway: Activation and regulation of the first complement component. Adv Immunol, 1985, 37: 151-216.
23. Kalesnikoff J, Huber M, Lam V, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity, 2001, 14: 801-811.
24. Leibson P J. Signal transduction during natural killer cell activation: Inside the mind of a killer. Immunity, 1997, 6: 655-661.
25. Takai T. Multiple loss of effector cell functions in FcR gammadeficient mice. Int Rev Immunol, 1996, 13: 369-381.
26. Kim K D, Zhao J, Yang X, et al. Adaptive immune cells temper initial innate responses. Nat Med, 2007, 13: 1248-1252.
27. Kim K D, Zhao J, Auh S, et al. Adaptive immune cells temper initial innate responses. Nat Med, 2007, 13: 1248-1252.
28. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med, 2003, 197: 111-119.
29. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol, 2006, 176: 1582-1587.
30. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA, 2007, 104: 19446-19451.
31. Garrett W S, Lord G M, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell, 2007, 131: 33-45.
32. Miyara M, Sakaguchi S. Natural regulatory T cells: Mechanisms of suppression. Trends Mol Med, 2007, 13: 108-116.
33. Lund J M, Hsing L, Pham T T, et al. Coordination of early protective immunity to viral infection by regulatory T cells. Science, 2008, 320: 1220-1224.
34. Zhang X, Deriaud E, Jiao X, et al. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med, 2007, 204: 1107-1118.
35. Zhao J, Kim K D, Yang X, et al. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci USA, 2008, 105: 7528-7533.
36. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol, 2004, 4: 553-564.
37. Levy O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol, 2007, 7: 379-390.
38. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4: 336-347.
39. Sun Y, Brown N K, Ruddy M J, et al. B and T lymphocyte attenuator tempers early infection immunity. J Immunol, 2009, 183: 1946-1951.
40. Franchi L, Eigenbrod T, Munoz-Planillo R, et al. The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol, 2009, 10: 241-247.
41. Martinon F, Mayor A, Tschopp J. The inflammasomes: Guardians of the body. Annu Rev Immunol, 2009, 27: 229-265.
42. Ogura Y, Sutterwala F S, Flavell R A. The inflammasome: First line of the immune response to cell stress. Cell, 2006, 126: 659-662.
43. Tschopp J, Martinon F, Burns K. NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol, 2003, 4: 95-104.
44. Church L D, Cook G P, McDermott M F. Primer: Inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol, 2008, 4: 34-42.
45. McDermott M F, Tschopp J. From inflammasomes to fevers, crystals and hypertension: How basic research explains inflammatory diseases. Trends Mol Med, 2007, 13: 381-388.
46. Guarda G, Dostert C, Staehli F, et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature, 2009, 460: 269-273.
47. O'sullivan B, Thomas R. CD40 and dendritic cell function. Crit Rev Immunol, 2003, 23: 83-107.
48. Litman G W, Cannon J P, Dishaw L J. Reconstructing immune phylogeny: new perspectives. Nat Rev Immunol, 2005, 5: 866-879.
49. Aggarwal K, Silverman N. Positive and negative regulation of the Drosophila immune response. BMB Rep, 2008, 41: 267-277.
50. Liew F Y, Xu D, Brint E K, et al. Negative regulation of toll-like receptor mediated immune responses. Nat Rev Immunol, 2005, 5: 446-458.
51. Thomas R M, Linch D C. Identification of lymphocyte subsets in the newborn using a variety of monoclonal antibodies. Arch Dis Child, 1983, 58: 34-38.
52. Heldrup J, Kalm O, Prellner K. Blood T and B lymphocyte subpopulations in healthy infants and children. Acta Paediatr, 1992, 81: 125-132.
53. Kumar A, Jauhari P, Singh U, et al. Quantitation of T cells in venous blood of healthy neonates. Indian J Pediatr, 1994, 61: 711-714.
54. Atici A, Satar M, Cetíner S, et al. Serum tumor necrosis factor-alpha in neonatal sepsis. Am J Perinatol, 1997, 14: 401-404.
55. Blackwell C C, Moscovis S M, Gordon A E, et al. Cytokine responses and sudden infant death syndrome: Genetic, developmental, and environmental risk factors. J Leukoc Biol, 2005, 78: 1242-1254.
56. Ozdemir A, Oygür N, Gültekin M, et al. Neonatal tumor necrosis factor, interleukin-1 alpha, interleukin-1 beta, and interleukin-6 response to infection. Am J Perinatol, 1994, 11: 282-285.
57. Vege A, Rognum T O, Aasen A O, et al. Are elevated cerebrospinal fluid levels of IL-6 in sudden unexplained deaths, infectious deaths and deaths due to heart/lung disease in infants and children due to hypoxia? Acta Paediatr, 1998, 87: 819-824.
58. Vege A, Rognum T O, Scott H, et al. SIDS cases have increased levels of interleukin-6 in cerebrospinal fluid. Acta Paediatr, 1995, 84: 193-196.
59. Palm N W, Medzhitov, R. Not so fast: Adaptive suppression of innate immunity. Nat Med, 2007, 13: 1142-1144.